# OnCo record nct06328738 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06328738/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06328738", "NCT06328738" ;
  schema:name "ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer"@en ;
  schema:description "A phase 1 trial of ELVN-002 run by Enliven Therapeutics, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06328738/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06328738> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/gastric-her2-positive/>, <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/elvn-002/> ;
  onco:companies <https://onco.cc/companies/enliven-therapeutics/> .